This antibody was purified from hybridoma (clone MIH3) supernatant using protein A agarose. This hybridoma was established by fusion of mouse myeloma cell SP2/0 with Balb/c mouse splenocyte immunized with the full-length human PD-L1 transfected L cells.
Target:
CD274
Application Dilute:
FCM: 5-10 ug/mL (final concentration)
* VAT and and shipping costs not included. Errors and price changes excepted